This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., University of Regensburg. Active years: 2023.
Company Filing History:
1 out of 4,917 
1 out of 14 
Years Active: 2023
Title: The Innovative Contributions of Isabelle Hodak
Introduction
Isabelle Hodak is a prominent inventor based in Munich, Germany. She has made significant strides in the field of cancer research, particularly in the diagnosis and treatment of melanoma. Her innovative approach has led to the development of a patented method that enhances the understanding of cancerous diseases.
Latest Patents
Isabelle Hodak holds a patent titled "Means and methods for staging, typing and treating a cancerous disease." This invention focuses on methods for diagnosing, staging, and treating cancer, specifically melanoma. The patent outlines techniques for determining the stage and type of cancer by detecting somatic alterations in the DNA of disseminated cancer cells (DCCs). These cells are obtained after homing to distant organs, such as lymph nodes. The methods described in her patent provide crucial insights into the somatic evolution of DCCs, which is indicative of the cancer's stage and type.
Career Highlights
Throughout her career, Isabelle has worked with esteemed organizations, including the Fraunhofer Society for the Advancement of Applied Research and the University of Regensburg. Her contributions to cancer research have been recognized within the scientific community, and her work continues to influence advancements in medical technology.
Collaborations
Isabelle has collaborated with notable colleagues, including Melanie Werner-Klein and Christoph Klein. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in cancer treatment.
Conclusion
Isabelle Hodak's contributions to cancer research through her innovative patent and collaborations with esteemed institutions highlight her commitment to advancing medical science. Her work is paving the way for improved diagnostic and treatment methods for cancer patients.